Flanders Innovation and Entrepreneurship (VLAIO)
VC Fund
Brussel, Belgium
Flanders Innovation and Entrepreneurship (VLAIO) is a VC fund in Brussel focused on Biotechnology and Health Care. Basic and applied research fund of the Flemish regional government in Belgium
- Total investments:
- 36
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Flanders Innovation and Entrepreneurship (VLAIO) invests in
Stages Flanders Innovation and Entrepreneurship (VLAIO) invests in
Countries Flanders Innovation and Entrepreneurship (VLAIO) invests in
Round sizes
Round size
- Seed
- $517k–$1.9M
- Grant
- $285k–$3.2M
- Pre-Seed
- $160k–$2.2M
Investment Focus
Industry
- Biotechnology 13 (36%)
- Health Care 8 (22%)
- Software 6 (17%)
- Artificial Intelligence 5 (14%)
- Medical 4 (11%)
Stage
- Grant 20 (56%)
- Pre-Seed 6 (17%)
- Seed 2 (6%)
- Debt Financing 2 (6%)
- Series A 1 (3%)
Country
- Belgium 26 (72%)
- Israel 1 (3%)
- Germany 1 (3%)
- Switzerland 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| A GDPR-compliant data-sharing solution that gives eCommerce stores access to accurate customer data for personalization, from the very first interaction. Personalization boosts user experience, conversion and lowers the CAC. At the same time we enable consumers to regain control of their data. WeHave solves the personalization - privacy paradox. | $200K / Pre-Seed / Apr 09, 2023 | ||
| Summ.link works to transform enterprises by enhancing the employee experience through strategy and strong insights based on trustworthy data, which leads to improvements in digital processes. By putting a strong emphasis on data intelligence and people analytics, it seeks to provide everyone in the organization with actionable information.Application development, big data, AI, cloud solutions, and other services are among their offerings. | $160K / Pre-Seed / Mar 01, 2023 | ||
| Gorilla's mission is to accelerate the transformation of the energy & utility industry with energy data applications.Data problems have existed for a long time. They have limited innovation in countless companies and industries due to a lack of technology and know-how on storing, handling, indexing, and processing the data at hand.Anycompany seeks to get the maximum ROI from its data in the shortest time possible. Yet, for way too long, IT leaders have sought standalone solutions to the data silo problem without considering future business requirements for data extraction, processing, and reporting.Gorilla made a breakthrough, providing energy companies with an architectural data foundation fit for their specific industry. The existing Gorilla data applications provide companies with a flexible data model, and a stable environment with reusable algorithms inside for a much faster digital transformation journey.Gorilla has offices in Antwerp, London, Austin and Melbourne | $6.3M / Series A / Dec 02, 2022 | ||
| IntelliProve is a MedTech company that develops computer technology capable of accurately determining health parameters based on an optical measurement of the face in a matter of seconds. It measures physiological and mental health parameters with a single smartphone click. Everything is contained within the healthcare platform.The company wasfounded in 2021 and is based in Ghent, Belgium. | Grant / Nov 15, 2022 | ||
| AYES creates an application that helps the 1 out of 4 Americans with a disability. Today, the AYES service not only utilizes AI to make daily travels seamless for blind and visually impaired people but also captures valuable visual data with each assistance provided. We've assisted in crossing over a million streets, enhancing independencealong the way. | $1M / Pre-Seed / Oct 18, 2022 | ||
| Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours. | $1.2M / Grant / Jun 14, 2021 | ||
| Let’s make healthcare understandable for both patients and caregivers, with the use of technology. Decode your medical reports, and understand your health. Tired of confusing medical jargon in your reports? ExplainMed has you covered. With our revolutionary online tool, simply scan your medical report and get a clear, concise translation of complexmedical terms, giving you the power to make informed decisions about your health. | $72.7K / Grant / Jun 01, 2021 | ||
| Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO body-stabilized active state conformations ofthese receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention. | $1.2M / Grant / Mar 30, 2021 | ||
| Resortecs leads the circular transition in fashion with Design for Disassembly. We empower brands, sorters, and recyclers with heat-dissolvable stitching threads and thermal disassembly systems that make recycling easy. Through targeted innovations in the way textile products are assembled and disassembled, we help fashion players rise totoday’s environmental challenges at the pace and scale Earth needs. All without compromising the creativity, design, and quality of clothing.Resortecs' thermal disassembly solution is five times faster than traditional disassembly methods and makes it possible to recycle up to 90% of the original fabric material: • Smart Stitch™, our heat-dissolvable stitching thread with different melting points (150 °C, 170 °C and 190 °C), enables brands to transform their products into recyclable, circular pieces from the manufacturing stage. • Smart Disassembly™, our thermal disassembly system, enables recyclers to unlock higher volumes of premium-quality material, processing up to 4M garments/year with low emissions and no material damage so that fabrics can be used over and over again. Welcome to sustainability's next level: circularity. | $2.2M / Pre-Seed / Jan 31, 2021 | ||
| At Stellar Labs, we're disrupting Workplace Learning with our groundbreaking AI-Designer and Skillbuilder. Our unique approach, powered by the neuroscience-based GEAR methodology, is designed to transform professional learning making it more efficient, engaging, and effective than ever before. Key Features:- Rapid Design & Delivery:Our AI-driven design allows learning experiences to be created in minutes and launched in days, not months. This agility ensures that your organisation can quickly adapt to new challenges and opportunities.- Evidence-based learning: Leveraging the latest neuroscience, our platform ensures that all training is optimised for maximum knowledge retention and real-world application.- Adaptive Learning Paths: AI personalisation tailors the learning experience to each individual, increasing engagement, performance and productivity.- Measurable Results: Focused on delivering tangible results, we provide insight into performance improvements and productivity gains across your workforce.Stellar Labs isn't just about delivering content; it's about creating a learning culture that adapts, evolves and grows with your organisation. Our platform is designed to improve performance and productivity where it matters most, ensuring your team is equipped with the skills they need for the future.With Stellar Labs, you empower your workforce, accelerate skill acquisition and unlock unprecedented levels of performance and productivity. | $1.9M / Seed / Dec 22, 2020 | ||
| See all 36 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Flanders Innovation and Entrepreneurship (VLAIO) invest in?
Flanders Innovation and Entrepreneurship (VLAIO) invests primarily in Biotechnology, Health Care and Software startups, most often at Grant and Pre-Seed stage. Most of the 36 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Flanders Innovation and Entrepreneurship (VLAIO) invest in?
Flanders Innovation and Entrepreneurship (VLAIO) typically joins rounds of $517k–$1.9M at Seed, $285k–$3.2M at Grant and $160k–$2.2M at Pre-Seed. These are whole funding-round sizes, not Flanders Innovation and Entrepreneurship (VLAIO)'s own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Flanders Innovation and Entrepreneurship (VLAIO) took part in.
When did Flanders Innovation and Entrepreneurship (VLAIO) last invest?
The most recent investment recorded for Flanders Innovation and Entrepreneurship (VLAIO) closed in Apr 2023. Shizune tracks 36 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
